(Q26850961)

J. D. Allen

series ordinal

2

1 reference

J. A. Nowak

series ordinal

3

1 reference

S. E. Bates

series ordinal

4

1 reference

language of work or name

1 reference

15 March 2014

1 reference

published in

Clinical Cancer Research

1 reference

volume

20

1 reference

issue

6

1 reference

page(s)

1419-27

1 reference

MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia.

cites work

1 reference

12 December 2020

L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma

1 reference

12 December 2020

Quality in cancer diagnosis

1 reference

12 December 2020

The Health Technology Assessment of companion diagnostics: experience of NICE.

1 reference

12 December 2020

MYD88 L265P mutation in Waldenstrom macroglobulinemia.

1 reference

12 December 2020

ERCC1 measurements in clinical oncology

1 reference

12 December 2020

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

1 reference

12 December 2020

ERCC1 isoform expression and DNA repair in non-small-cell lung cancer

1 reference

12 December 2020

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.

1 reference

12 December 2020

Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays

1 reference

12 December 2020

NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry

1 reference

12 December 2020

Current issues in ER and HER2 testing by IHC in breast cancer

1 reference

12 December 2020

Cancer drug development and the evolving regulatory framework for companion diagnostics in the European union

1 reference

12 December 2020

Excision repair cross complementing-group 1: gene expression and platinum resistance.

1 reference

12 December 2020

Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer

1 reference

12 December 2020

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction

1 reference

12 December 2020

1 reference

12 December 2020

The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis

1 reference

12 December 2020

Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

1 reference

12 December 2020

FDA perspective on companion diagnostics: an evolving paradigm

1 reference

12 December 2020

A new era for Waldenstrom macroglobulinemia: MYD88 L265P.

1 reference

12 December 2020

Evidence of clinical utility: an unmet need in molecular diagnostics for patients with cancer

1 reference

12 December 2020

MYD88 L265P somatic mutation in IgM MGUS

1 reference

12 December 2020

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

1 reference

12 December 2020

Implementing personalized cancer genomics in clinical trials

1 reference

12 December 2020

IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas

1 reference

12 December 2020

Analytical and clinical evaluation of biomarkers assays: when are biomarkers ready for prime time?

1 reference

12 December 2020

ERCC1 and RRM1: ready for prime time?

1 reference

12 December 2020

First FDA authorization for next-generation sequencer

1 reference

12 December 2020

10.1158/1078-0432.CCR-14-0091

Identifiers

DOI

1 reference

0 references

PubMed publication ID

24634465

1 reference